Literature DB >> 6301665

Dose-related effects of furosemide, bumetanide, and piretanide on the thick ascending limb function in the rat.

H U Gutsche, K Müller-Ott, R Brunkhorst, W Niedermayer.   

Abstract

To assess the action of piretanide, bumetanide, and furosemide on the thick ascending limb of Henle's loop, perfusion experiments were performed on rat kidneys, using a recently developed conductivity microprobe for the analysis of distal tubular fluid. Surface nephrons were perfused downstream from a solid paraffin block through Henle's loop with isotonic saline solution containing either 10(-6), 3 X 10(-6), or 10(-5) mol/L piretanide, bumetanide, or furosemide, respectively. For control values, diuretic-free saline was used. Conductivity measurements of early distal tubular fluid were performed in situ with a conductivity microprobe and were recorded continuously during variations of loop perfusion rate. A recently described micro-stop-flow technique was used to measure the conductivity of fluid emerging from the ascending limb, thereby evaluating the amount of sodium chloride reabsorbed. A significant electrolyte transport inhibition occurred within the concentration range between 10(-6) and 10(-4) M. Bumetanide and piretanide were slightly more effective than furosemide. Luminal diuretic concentrations of 10(-6) M or below were without influence on electrolyte reabsorption. Concentrations of 10(-4) M resulted in complete inhibition of the diluting segment electrolyte transfer.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6301665     DOI: 10.1139/y83-024

Source DB:  PubMed          Journal:  Can J Physiol Pharmacol        ISSN: 0008-4212            Impact factor:   2.273


  5 in total

1.  In vivo evidence of impaired solute transport by the thick ascending limb in potassium-depleted rats.

Authors:  H U Gutsche; L N Peterson; D Z Levine
Journal:  J Clin Invest       Date:  1984-04       Impact factor: 14.808

Review 2.  Piretanide. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy.

Authors:  S P Clissold; R N Brogden
Journal:  Drugs       Date:  1985-06       Impact factor: 9.546

3.  Furosemide inhibits glucose transport in isolated rat adipocytes via direct inactivation of carrier proteins.

Authors:  D B Jacobs; B K Mookerjee; C Y Jung
Journal:  J Clin Invest       Date:  1984-11       Impact factor: 14.808

Review 4.  Bumetanide. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use.

Authors:  A Ward; R C Heel
Journal:  Drugs       Date:  1984-11       Impact factor: 9.546

5.  Pharmacokinetics of the loop diuretic piretanide in renal failure.

Authors:  U Walter; A Röckel; W Lahn; A Heidland; W Heptner
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.